Adjuvant methotrexate in CIDP.
Dyck
Peter James
PJ
D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000627:therapeutic use*; D008727:Methotrexate / Q000737:chemistry / Q000627:therapeutic use*; D008958:Models, Molecular; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic
D007166:Immunosuppressive Agents; D008727:Methotrexate